Sample Prep for Viral RNA Capture with LASSO

Team Dynamic Matrices | 2026-07-24

Most conversations about nucleic acid capture start with the capture step itself: which chemistry, which beads, which enzyme. But by the time a sample reaches that step, its fate is largely decided. If the virus was lysed too harshly, if the RNA started degrading before it ever touched a reagent, or if inhibitors from the original matrix are still floating around, no capture method can fully undo that damage. This is especially true for a platform like LASSO, which is built around gentleness as a core design principle. Getting the most out of it means treating sample preparation as part of the assay, not a chore that happens before the real work begins.

Why Sample Prep Matters More with a Gentle Capture Method

Conventional pulldown methods, magnetic beads with harsh binding buffers or enzymatic digestion followed by column cleanup, are somewhat forgiving of a messy starting sample. They apply enough chemical force to strip away a lot of surrounding material regardless of how it arrived. LASSO takes a different approach. It relies on dynamic DNA crosslinker libraries that trigger a phase change in solution, allowing a polymer network to self-assemble around the target molecule and selectively engulf it while leaving everything else behind. That selectivity is the whole point: it is what allows viral RNA to be captured directly from a patient sample under native conditions, without the degradation that comes from more aggressive chemistries.

The tradeoff is that a gentle system is more sensitive to what it is given. If a sample still carries heparin, hemoglobin, or excess protein from an incomplete lysis, those contaminants can compete with the intended target during self-assembly, or interfere with how cleanly the crosslinker library reads the target's identity. Good sample prep is what lets the platform's selectivity actually show up in the data instead of getting diluted by background noise.

Start with the Lysis Step

For viral RNA work, lysis needs to accomplish two things at once: release the RNA from the viral particle and the surrounding matrix, and do so without shredding it in the process. A few practical points make a real difference here.

Chaotropic lysis buffers used in standard extraction kits are effective at inactivating nucleases quickly, which is valuable, but many are formulated with high salt concentrations that need to be diluted or buffer-exchanged before a gentle capture step will work well. If a lysate is going straight into a LASSO capture rather than a full extraction, it is worth using a lower-stringency lysis buffer that still deactivates RNases but leaves the sample closer to physiological ionic strength.

Mechanical lysis, bead beating or sonication, should be used sparingly if at all for RNA work. Shear forces that are perfectly fine for breaking open cell membranes can fragment longer RNA species, which matters if downstream sequencing or functional assays depend on read length or transcript integrity. For viral particles specifically, a detergent-based lysis (nonionic detergents like Triton X-100 or NP-40 at low concentration) is usually sufficient and much gentler on the RNA that comes out.

Keep RNase Contamination Out from the Start

This is not a new rule, but it deserves repeating because it is the single most common source of failed captures regardless of which platform is used downstream. RNase A is present on skin and in dust, and it survives a surprising range of conditions. Use RNase-free consumables, decontaminate work surfaces before starting, and avoid touching the inside of tube caps or pipette tips. Include an RNase inhibitor in the lysis buffer if the sample will sit for any length of time before capture, and process samples on ice whenever possible to slow enzymatic activity.

For clinical samples in particular, where collection and lysis may happen in a different location or at a different time than the actual capture experiment, RNA stabilization reagents (commercial stabilizers or a simple guanidinium-based stopping solution) are worth the extra step. A sample that degrades in transit cannot be rescued by even the most selective capture chemistry.

Clear Out the Inhibitors

Clinical and environmental samples often carry compounds that interfere with downstream molecular work: heme and its degradation products from blood, humic acids from environmental samples, polysaccharides from plant or soil material, and residual detergents or salts from the lysis buffer itself. These do not necessarily block LASSO's crosslinker-driven selectivity directly, but they can slow the phase change, compete for space in the forming polymer network, or interfere with any quantification step that follows.

A short clarification spin (10,000 x g for a few minutes) to pellet cell debris before capture removes a lot of particulate interference at essentially no cost. For samples with higher protein content, a brief proteinase K digestion followed by heat inactivation can clean things up further, as long as the digestion is short enough that it does not itself become a source of RNA degradation.

Match the Pre-Treatment to What You Actually Need Downstream

Sample prep is not one-size-fits-all, and the right amount of processing depends on what happens after capture. A few common scenarios:

For diagnostic viral RNA detection, where the endpoint is a PCR or sequencing readout rather than functional or structural studies, a fairly standard lysis and clarification is usually enough. Preserving the RNA's native fold matters less than preserving its sequence and its accessibility to the crosslinker library.

For studies where secondary structure or protein-RNA interactions are part of the question, native conditions matter throughout the whole workflow, not just at the capture step. That means avoiding heat steps, minimizing time at room temperature, and choosing lysis conditions that keep the sample as close to physiological as the assay allows.

For low-titer samples, where the viral RNA of interest is a small fraction of total nucleic acid in the lysate, concentrating the sample before capture (through a spin concentrator or a brief precipitation step) can meaningfully improve capture efficiency. LASSO's selectivity reduces the need to purify away background nucleic acid before capture, but it cannot manufacture target molecules that were too dilute to begin with.

A Simple Pre-Capture Checklist

Before a lysate goes into a LASSO capture, it helps to run through a short set of questions. Has the sample been kept cold or stabilized since collection. Has an RNase inhibitor been included if there is any delay before capture. Has particulate debris been cleared by a short spin. Is the buffer close enough to the ionic strength the capture chemistry expects, or does it need a quick dilution or exchange step. None of these are complicated on their own, but skipping any one of them is a common reason a capture underperforms even when the chemistry itself is sound.

The Bigger Picture

Dynamic DNA crosslinker technology exists because conventional capture methods force a choice between selectivity and gentleness. LASSO is designed to avoid that tradeoff, but it can only do so if the sample it receives has not already been compromised upstream. Treating lysis, stabilization, and clarification as integral parts of the capture workflow, rather than as separate housekeeping steps, is what turns the platform's underlying selectivity into consistent, reproducible results on the bench.